Chennai Meenakshi Multispecial
BSE: CMMHOSP · Healthcare Service Provider · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹5 cr vs borrowings ₹11 cr (FY26): borrowings are higher by ₹5 cr.
- Operating profit covered interest 0.5x in the last 12 months.
- Net loss in 3 of the last 6 quarters.
- No dividend in the last 5 financial years.
- Price ₹35.01 on 2026-10-26: -39.1% from the 52-week high, +11.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 9 | 9 | 9 | 9 | 10 | 9 |
| EBITDA | 0 | -1 | 0 | -0 | 0 | 0 |
| OPM % | 3.8% | -6.0% | 3.2% | -3.6% | 2.4% | 4.0% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | 0 | -1 | 0 | -1 | -0 | 0 |
| EPS (₹) | 0.42 | 0.99 | 0.20 | 0.72 | 0.03 | 0.00 |
| Revenue YoY | +7.0% | -0.7% | ||||
| Profit YoY | -106.5% | – |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 31 | 28 | 38 | 35 | 37 | 37 |
| EBITDA | 6 | 3 | 2 | -0 | -0 | 1 |
| Net profit | 4 | 1 | -0 | -1 | -1 | -0 |
| EPS (₹) | 5.32 | 1.19 | -0.57 | 1.84 | 1.50 | 0.95 |
| Revenue growth | -9.2% | +34.3% | -8.8% | +6.4% | – | |
| Profit growth | -77.6% | -148.3% | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +9.2% | – | – |
| Net profit | – | – | – |
| EPS | +8.0% | – | – |
| Share price | – | -2.6% (2y) | -29.1% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | -2 | -3 |
| Borrowings | 11 | 11 |
| Cash & equivalents | 3 | 5 |
| Total assets | 23 | 21 |
| Fixed assets | 14 | 13 |
| Capital work in progress | – | 0 |
| Investments | 0 | 0 |
| Receivables | 1 | 1 |
| Inventory | 0 | 0 |
| Payables | 0 | 2 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 2 | 0 |
| Cash from investing | -1 | -2 |
| Cash from financing | -2 | -1 |
| Capex | 1 | 0 |
| Free cash flow | 1 | 0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 72.8% | 36.3% |
| ROCE % | -5.9% | -3.3% |
| Debtor days | 8 | 9 |
| Inventory days | 25 | 21 |
| Payable days | 0 | 73 |
| Cash conversion cycle (days) | 33 | -43 |
| Working capital days | -60 | -40 |
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 29.6% | 27.9% | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 30.1% | 42.2% | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 19.7% | 24.2% | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 39.7% | 31.4% | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 13.4% | 22.7% | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 25.2% | 31.4% | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 11.1% | 26.8% | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 22.8% | 34.9% | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | – | – | – | – |
| CMMHOSP | ₹26 cr | 36.9x | – | – | 6.0% | 1.5% | +9.2% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2002-11-27 | Dividend | Final Dividend |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | CMMHOSP |
| BSE code | 523489 |
| ISIN | INE889F01017 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.